Skip to content

Contract award record

NHS Branded Medicines Framework for North of England and Midlands and East - 1 March 2024

Tender value £580,156,000

Notice details

Published
Category
goods
Buyer region
North West

Public buyer and contract winner

Public buyer

NHS England
awarded to

Contract winner

Zentiva Pharma UK Ltd

Award value£688,010,000

  1. Awarded
    Completed
  2. Start
    Completed
  3. End
    Completed

Work description

Project Title: NHS Branded Medicines Framework for North of England and Midlands and East - 1 March 2024

Offer reference number: CM/PHR/22/5678

CM/PHR/22/5678/01 - NHS Framework for NORTH OF ENGLAND Branded Medicines - Tranche B. Period of framework: 1 March 2024 to 31 August 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.

CM/PHR/22/5678/02 - NHS Framework for NORTH OF ENGLAND Branded Medicines (to transition to Tranche B) Period of framework: 1 March 2024 to 31 August 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.

CM/PHR/22/5678/03 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines - Tranche A. Period of framework: 1 March 2024 to 31 August 2026 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months

CM/PHR/22/5678/04 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines (to transition to Tranche B). Period of framework: 1 March 2024 to 31 August 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months

Related awards

Source: Contracts Finder · Notice c7b18c5b-1199-4503-86c0-f922d2e06c42-726527

View source notice